Filtros de búsqueda

Lista de obras de Matthew Mei

Allogeneic Hematopoietic Cell Transplantation Outcomes in Patients Carrying Isocitrate Dehydrogenase Mutations.

artículo científico publicado en 2019

Association between Clonal Hematopoiesis and Late Nonrelapse Mortality after Autologous Hematopoietic Cell Transplantation

scientific article published on 22 August 2019

Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

scientific article published on 10 July 2019

Autologous Stem Cell Transplantation After Second Line Brentuximab Vedotin in Relapsed or Refractory Hodgkin Lymphoma.

artículo científico publicado en 2017

Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.

artículo científico publicado en 2018

Characteristics and Trends of Adult Acute Lymphoblastic Leukemia in a Large, Public Safety-Net Hospital

artículo científico publicado en 2020

Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

scholarly article by Ibrahim Aldoss et al published September 2018 in Haematologica

How to Approach a Hodgkin Lymphoma Patient With Relapse After Autologous SCT: Allogeneic SCT.

artículo científico publicado en 2017

Hypomethylating agents in combination with venetoclax for acute myeloid leukemia: Update on clinical trial data and practical considerations for use

scientific article published on 13 December 2018

Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma

artículo científico publicado en 2020

Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

scientific article published on 06 December 2019

Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents

scientific article published on 01 December 2019

Long-Term Outcomes of Patients with Acute Myelogenous Leukemia Treated with Myeloablative Fractionated Total Body Irradiation TBI-Based Conditioning with a Tacrolimus- and Sirolimus-Based Graft-versus-Host Disease Prophylaxis Regimen: 6-Year Follow-

artículo científico publicado en 2019

Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance Rituximab.

artículo científico publicado en 2017

Long-term Outcomes of Allogeneic Hematopoietic Cell transplantation with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as GVHD prophylaxis in Patients with Acute Lymphoblastic Leukemia

artículo científico publicado en 2020

MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen

Management of relapsed or refractory hodgkin lymphoma with second-generation antibody-drug conjugates: focus on brentuximab vedotin.

artículo científico

Measuring the Value of New Drugs: Validity and Reliability of 4 Value Assessment Frameworks in the Oncology Setting.

artículo científico publicado en 2017

Melphalan-Based Reduced Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

artículo científico publicado en 2018

Outcome of allogeneic hematopoietic cell transplantation after venetoclax and hypomethylating agent therapy for acute myeloid leukemia

scientific article published on 28 August 2020

Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

artículo científico publicado en 2020

Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD Prophylaxis

artículo científico publicado en 2018

Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation

artículo científico publicado en 2020

P38 activation mediates amyloid-beta cytotoxicity

artículo científico publicado en 2005

Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria Clones

scientific article published on 29 January 2019

Pulmonary hypertension is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation for myelofibrosis

scientific article published on 06 November 2019

Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma

scientific article published on 10 December 2018

Second primary malignancies after autologous hematopoietic cell transplantation for multiple myeloma

artículo científico publicado en 2012

The role of transplant in multiple myeloma

artículo científico publicado en 2014

Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients

scholarly article by Ibrahim Aldoss et al published October 2018 in Haematologica

Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs.

artículo científico publicado en 2017

Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia

artículo científico publicado en 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda